Search for: "BRISTOL-MYERS SQUIBB COMPANY"
Results 221 - 240
of 465
Sort by Relevance
|
Sort by Date
30 Dec 2013, 5:25 am
Bristol-Myers Squibb Co., 916 F. [read post]
19 Dec 2013, 1:03 pm
Bristol Myers Squibb Co., No. 96 689 CIV ORL 19B, 1998 WL 812318 (M.D. [read post]
12 Dec 2013, 7:12 am
In the meantime, here they are in outline:Case C‑443/12, Actavis Group PTC EHF, Actavis UK Ltd v Sanofi, Sanofi Pharma Bristol-Myers Squibb SNC intervening, noted on The SPC Blog here. [read post]
11 Dec 2013, 4:30 am
Bristol-Myers Squibb Co., 2013 U.S. [read post]
5 Aug 2013, 9:59 pm
The UK High Court recently gave its judgment in the case of Merck, Sharp & Dohme Corp. and Bristol-Myers Squibb Pharmaceuticals Ltd (collectively referred to in the judgement as BMS) v Teva Pharma B.V. and Teva UK Ltd (Teva) (decision). [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
29 Jul 2013, 2:24 am
Unfortunately,without any thumbs, he was unable to forwardthem to the true recipient, Bristol-Myers Squibb When the parties engaged in correspondence, Teva refused to divulge its launch plans as it considered these plans confidential. [read post]
28 Jul 2013, 9:29 am
Byetta, now sold by Bristol-Myers Squibb and AstraZeneca, was approved in 2005 and contained a warning about pancreatitis. [read post]
14 Jun 2013, 9:22 pm
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff; and Paul Golian, Assistant General Counsel at Bristol-Myers Squibb Company will consider such questions as: • How many and which existing gene patents will be challenged in post-grant proceedings at the USPTO? [read post]
14 Jun 2013, 6:23 pm
The Food and Drug Administration said it is considering setting up a study, either through the agency or the companies, that looks deeper into whether medicines for Type 2 diabetes, including Merck’s Januvia and Bristol Myers-Squibb Co. [read post]
12 Jun 2013, 12:50 pm
The concerns relate to a number of widely prescribed GLP-1–based therapies, the 2 injectable GLP-1 agonists, exenatide (Byetta, Amylin/Lilly) and liraglutide (Victoza, Novo Nordisk), and the oral DPP-4 inhibitors sitagliptin, saxagliptin (Ongylza, AstraZeneca/Bristol-Myers Squibb), and linagliptin (Tradjenta, Boehringer Ingelheim/Lilly). [read post]
10 Jun 2013, 11:23 am
Thakur began his work at Ranbaxy in early 2004 after he was recruited from the brand-name pharmaceutical company Bristol-Myers Squibb (BMY) based out of New Jersey. [read post]
6 Jun 2013, 5:00 am
Bristol-Myers Squibb Co., No. 12 Civ. 2238 (JPO), slip op. [read post]
5 Jun 2013, 5:29 am
Bristol-Myers Squibb, 97 F. [read post]
30 Apr 2013, 12:14 pm
Bristol-Myers Squibb Company, 2013 U.S. [read post]
26 Feb 2013, 9:02 am
On the agenda: • Two keynote addresses by USPTO’s Teresa Stanek Rea and WIPO’s James Pooley • AIA and NPEs: one year on • Lessons from Canadian reforms • Monetization of patents: strategies for deriving maximum value from your patent portfolio • Life sciences & ITC industries focus • Doing business in China: how to ensure your patented assets in China are making you money Speakers: • James Pooley, deputy director general for innovation and… [read post]
20 Feb 2013, 7:37 am
Bristol-Myers Squibb Company v. [read post]
15 Feb 2013, 9:29 am
Bristol-Myers Squibb Company v. [read post]
13 Feb 2013, 11:49 pm
For those interested, the Indian patent number is 213457 and the case details are: Bristol-Myers Squibb Company v. [read post]
31 Jan 2013, 2:39 pm
Earlier in February, 2006 Emcure entered into a similar deal with Bristol Myers Squibbs (BMS) for the manufacture of atanzanavir. [read post]
